Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Clay Faquin, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by William Faquin and Frederic Jakobiec.
Connection Strength

0.785
  1. High Expression of Programmed Death Ligand 1 and Programmed Death Ligand 2 in Ophthalmic Sebaceous Carcinoma: The Case for a Clinical Trial of Checkpoint Inhibitors. Am J Ophthalmol. 2020 12; 220:128-139.
    View in: PubMed
    Score: 0.231
  2. Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications. Am J Ophthalmol. 2019 04; 200:226-241.
    View in: PubMed
    Score: 0.208
  3. p16 Expression Is Not a Surrogate Marker for High-Risk Human Papillomavirus Infection in Periocular Sebaceous Carcinoma. Am J Ophthalmol. 2016 Oct; 170:168-175.
    View in: PubMed
    Score: 0.175
  4. Evaluation for High-risk HPV in Squamous Cell Carcinomas and Precursor Lesions Arising in the Conjunctiva and Lacrimal Sac. Am J Surg Pathol. 2016 Apr; 40(4):519-28.
    View in: PubMed
    Score: 0.171
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.